Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study

J Am Acad Dermatol. 2024 Jan;90(1):134-137. doi: 10.1016/j.jaad.2023.08.025. Epub 2023 Aug 19.

¹ Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: mschneeweiss@bwh.harvard.edu.
² Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
³ Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
⁴ Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
⁵ Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Division of Rheumatology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

No abstract available

Keywords: arthralgia; arthritis; atopic dermatitis; dupilumab; epidemiology; immunomodulating drugs; safety; systemic medications.

MeSH terms